Altered bioavailability of tacrolimus following intravenous administration of tigecycline.
Malleshappa
M
Pavan
Anup P
AP
Chaudhari
Ravi
R
Ranganth
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001682:Biological Availability; D004347:Drug Interactions; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016559:Tacrolimus / Q000493:pharmacokinetics*; D000078304:Tigecycline
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D000078304:Tigecycline; D008911:Minocycline; D016559:Tacrolimus